As cellular therapy products often cross international borders, it is important to be aware of applicable regulations in other regions. Products shipped across international borders must meet regulatory requirements of the competent authority of the exporting and importing country. Information on some non-U.S. competent authorities can be accessed via the links provided below. The information for each country is meant to serve as a resource, not a substitute for regulatory information or legal advice. Additionally, the information on this page is not updated in real-time, please contact the relevant competent authority to receive the most up-to-date information.
AABB2026: Book Signings for Biotherapies Manual, Technical Manual Set for AABB Annual Meeting
October 06, 2026
FDA Updates Biological Product Deviation Reporting Codes
October 05, 2026
New Biotherapies Supplement Now Available From Transfusion
October 02, 2026